Produkty 4004-68-6

CAS 4004-68-6 występuje w naszej ofercie pod nazwami: 5Alpha-Dihydrocortisol 21-Acetate, 5a-Dihydrocortisol 21-Acetate. Oferty producentów: TRC, Biosynth. Dostępne opakowania: 10mg, 25mg, 5mg, 50mg, 100mg.

5Alpha-Dihydrocortisol 21-Acetate
TRC
  • opakowanie: 10mg, 5mg
  • Warianty: 2
Zobacz produkt
5a-Dihydrocortisol 21-Acetate
TRC, Biosynth
  • opakowanie: 25mg, 10mg, 5mg, 50mg
  • Warianty: 6
Zobacz produkt
Wzór strukturalny: {0} (CAS {1})

[2-(11,17-dihydroxy-10,13-dimethyl-3-oxo-2,4,5,6,7,8,9,11,12,14,15,16-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl)-2-oxoethyl] acetate (CAS 4004-68-6) to związek chemiczny o wzorze sumarycznym C23H34O6 i masie molowej 406.5 g/mol. Nazwa systematyczna IUPAC: [2-(11,17-dihydroxy-10,13-dimethyl-3-oxo-2,4,5,6,7,8,9,11,12,14,15,16-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl)-2-oxoethyl] acetate. InChIKey: BWCPGWRDUCWIIR-UHFFFAOYSA-N.

Dane identyfikacyjne
Wzór sumarycznyC23H34O6
Masa molowa406.5 g/mol
Nazwa IUPAC[2-(11,17-dihydroxy-10,13-dimethyl-3-oxo-2,4,5,6,7,8,9,11,12,14,15,16-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl)-2-oxoethyl] acetate
InChIKeyBWCPGWRDUCWIIR-UHFFFAOYSA-N
SMILESCC(=O)OCC(=O)C1(CCC2C1(CC(C3C2CCC4C3(CCC(=O)C4)C)O)C)O

Dane obliczone przez PubChem (NCBI)

Synonimy: 11,17-Dihydroxy-3,20-dioxopregnan-21-yl acetate, 5alpha-Dihydrocortisol 21-acetate, Hydrallostane 21-acetate, 5.alpha.-Pregnane-3, 11.beta.,17,21-trihydroxy-, 21-acetate, Pregnane-3, 21-(acetyloxy)-11,17-dihydroxy-, (5.alpha.,11.beta.)-
Powiązane formy tego związku
[2-[(5R,8S,9S,10S,11S,13S,14S,17R)-11,17-dihydroxy-10,13-dimethyl-3-oxo-2,4,5,6,7,8,9,11,12,14,15,16-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-oxoethyl] acetate C23H34O6
Izomery (ten sam wzór sumaryczny)
3-[(3S,5R,8R,9S,10S,12R,13S,14S,16S,17R)-3,12,14,16-tetrahydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]-2H-furan-5-one C23H34O6
[(1S,3S,7S,8S,8aR)-3-hydroxy-8-[2-[(2R,4R)-4-hydroxy-6-oxooxan-2-yl]ethyl]-7-methyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl] (2S)-2-(trideuteriomethyl)butanoate C23H34O6
[(1S,3S,7S,8S,8aR)-3-hydroxy-8-[2-[(2R,4R)-4-hydroxy-6-oxooxan-2-yl]ethyl]-7-methyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl] (2S)-2-methylbutanoate C23H34O6
[(1S,3R,7R,8S,8aR)-8-[2-[(2R,4R)-4-hydroxy-6-oxooxan-2-yl]ethyl]-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl] (3R)-3-hydroxybutanoate C23H34O6
[(2R)-2-[(8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-10,13-dimethyl-3-oxo-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-hydroxyethyl] acetate C23H34O6
1056-08-2 C23H34O6
[(1S,6S,7R,8S,8aR)-6-hydroxy-8-[2-[(2R,4R)-4-hydroxy-6-oxooxan-2-yl]ethyl]-7-methyl-1,2,6,7,8,8a-hexahydronaphthalen-1-yl] (2S)-2-methylbutanoate C23H34O6
[(1S,6S,7R,8S,8aR)-6-hydroxy-8-[2-[(2R,4R)-4-hydroxy-6-oxooxan-2-yl]ethyl]-7-methyl-1,2,6,7,8,8a-hexahydronaphthalen-1-yl] 2-(trideuteriomethyl)butanoate C23H34O6
[2-[(3R,5R,8S,9S,10S,13S,14S,17R)-3,17-dihydroxy-10,13-dimethyl-11-oxo-2,3,4,5,6,7,8,9,12,14,15,16-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-oxoethyl] acetate C23H34O6